Accelerating Lentivirus Manufacturing: Choosing The Right Plasmid Manufacturing Platform

In this webinar, Philippe Ledent, Chief Scientific Director at Xpress Biologics (now part of Sartorius), and Rakel Lopez de Maturana, Qualified Person & Regulatory Affairs Director at VIVEbiotech share how to streamline and ensure the success of lentiviral-based therapies, from process development through to market approval. Watch to learn about navigating regulatory compliance for plasmids in lentivirus manufacturing, ensuring a consistent manufacturing process and specifications from research-grade to GMP-grade plasmid manufacturing, and accelerating lentivirus manufacturing with an adaptable plasmid manufacturing platform.